FDA Inspection 1309420 — Amneal Pharmaceuticals, LLC
The FDA completed an inspection of Amneal Pharmaceuticals, LLC on April 30, 2026 in Piscataway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Piscataway, NJ (United States)